Cannabis

The three main species typically recognized within the Cannabis sativa L. family include Cannabis sativa, Cannabis indica and Cannabis ruderalis. The most well-known compounds found within the cannabis plant are THC, cannabidiol (CBD) and cannabinol (CBN).

CBD Oil: Health Benefits and Risks

There is a growing interest in CBD as a potential drug in the treatment of a wide spectrum of neurologic and neuropsychiatric disorders. However, caution must be taken.

Using a Portable Raman Spectrometer for Detection of THC

Does Smoking Cannabis Indoors Affect Children's Health?

Can Cannabis Use Alter Sperm DNA?

Hemp Seed Oil Health Benefits

Synthesizing Cannabis from Yeast

Health Effects of Eating Cannabis (Marijuana)

Cannabis Use and Acute Myocardial Infarctions in Young People

The Potential Advantages of Patient-Directed Cannabis Therapy

Cannabis and Psychosis

Does CBD Oil Work for Arthritis Pain?

Latest Cannabis News and Research

Teen cannabis use alters brain development and raises addiction risk

A systematic review reveals adolescent cannabis use alters brain structure, elevates addiction risk, and impacts cognitive outcomes during critical development.

29 Apr 2026

Study reveals high use of complementary health approaches in seniors

Researchers say the finding highlights the need for more evidence and better conversations about risks and benefits of mindfulness, yoga, tai chi, acupuncture, and other complementary health approaches.

25 Apr 2026

Psilocybin use rises among Americans amid growing clinical interest

The use of psilocybin, the hallucinogenic compound found in "magic mushrooms," is rising in the United States alongside de‑criminalization efforts in several states and local jurisdictions, as well as heightened interest by the general public.

23 Apr 2026

Heavy drinking linked to next day cognitive problems in students

When college students drink very heavily or to the point of blacking out, they're more likely to report poorer cognitive functioning the next day, like forgetting someone's name or having trouble making decisions, according to new research from the University of Oregon.

22 Apr 2026

Real-time tracking reveals gaps in recalled alcohol use symptoms

When young adults are asked to recall their drinking habits, their recollections may not always match what actually happened in their day-to-day lives, a new study suggests.

21 Apr 2026

CBD shows promise, but this review warns the hype is outpacing the science

A Neuropsychopharmacology Circumspectives article argues that cannabidiol has genuine therapeutic potential, especially in treatment-resistant pediatric epilepsy, but evidence for most other uses remains limited, heterogeneous, and not yet mature enough for broad clinical adoption. The authors also warn that poor retail product quality, inaccurate labeling, contaminants, hepatotoxicity risk, and drug interactions are major barriers to safe and effective real-world use.

20 Apr 2026

Teen cannabis use linked to slower growth in memory and thinking

Researchers from University of California San Diego have found that teenagers who begin using cannabis show slower gains in thinking and memory skills as they grow. The study, published on April 20, 2026 in Neuropsychopharmacology, analyzed data from more than 11,000 participants in the Adolescent Brain Cognitive Development (ABCD) Study, the largest long-term study of brain development in U.S. youth.

20 Apr 2026

New cell atlas reveals biological links to pregnancy complications

The biological connection between a pregnant woman and her developing baby has been mapped in unprecedented detail by UC San Francisco scientists, revealing new cell types and insights into conditions such as preeclampsia, preterm birth, and miscarriage.

8 Apr 2026

Smoking shrinks key brain regions while cannabis shows weaker effects

The study highlights brain changes from tobacco use and calls for more research on cannabis, as its effects on brain structure remain inadequately understood.

7 Apr 2026

Study finds addiction risk tied to reward and impulse genes

Most of the genetic risk for developing a substance use disorder comes from genes that broadly affect how our brains process rewards, regulate impulses and weigh consequences – not from genes that specifically influence substance use disorder or any single drug.

22 Mar 2026

Largest review finds no mental health benefits of medicinal cannabis

A landmark Lancet Psychiatry paper published today – the largest-ever review of the safety and efficacy of cannabinoids across a range of mental health conditions – found no evidence that medicinal cannabis is effective in treating anxiety, depression or post-traumatic stress disorder (PTSD).

16 Mar 2026

Cannabis, cocaine and amphetamines linked to higher stroke risk

Cannabis and other illicit drugs are associated with higher stroke risk, underscoring the importance of addressing substance use disorders in health strategies.

11 Mar 2026

Acute cannabis intoxication appears to broadly disrupt most of the memory systems

Smoking cannabis can do more than blur memories. It can reshape them.

10 Mar 2026

Largest genetic study classifies 14 psychiatric disorders into five major groups

Although mental disorders have multifactorial causes, genetics can explain some of them, yet this field remains largely unexplored in terms of guiding diagnoses and treatments.

9 Mar 2026

Recreational drugs significantly increase the risk of stroke

The recreational drugs cannabis, cocaine and amphetamines significantly increase the risk of stroke – including among younger users – Cambridge researchers have concluded after analyzing data from more than 100 million people.

9 Mar 2026

Could GLP-1 drugs help curb addiction? Large veteran study points to potential benefit

A large cohort study of more than 600,000 US veterans with type 2 diabetes found that initiating GLP-1 receptor agonists was associated with lower risks of developing substance use disorders compared with SGLT-2 inhibitors. Among veterans with existing substance use disorders, GLP-1 receptor agonist use was also linked to fewer overdose events, hospitalizations, and suicide-related outcomes.

8 Mar 2026

GLP-1 drugs may be effective at treating and preventing substance use disorders

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be effective at treating and preventing substance use disorders across all major addictive substances studied, suggesting these drugs target a common biological pathway underlying addiction.

4 Mar 2026